ChAdOx1 – AstraZeneca + University of Oxford vs placebo
Systemic reactogenicity events
ChAdOx1 – AstraZeneca + University of Oxford probably leads to higher systemic reactogenicity eventsi compared with placebo (moderate certainty).
1 finding from 1 review
- RR 3.93 [2.11, 7.29]1 study · 256 participantsModerate